Home / Stocks / AMRX

AMRX insider trading

Amneal Pharmaceuticals, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
0
Bought · 24 mo
$0
Buys · last 90 days
0 · $0
Most recent buy
—

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-08-13Daly Jason B.
EVP, Chief Legal Officer
Sold210,000$17.40$3.7M
2026-08-13Shah Nikita
Executive Vice President
Sold146,403$17.51$2.6M
2025-11-14Shah Nikita
Executive Vice President
Sold131,856$11.92$1.6M
2025-08-25Shah Nikita
Executive Vice President
Sold114,492$9.66$1.1M
2025-08-22BOYER ANDREW S
Executive Vice President
Sold279,244$9.38$2.6M
2025-08-15Konidaris Tasos
Executive Vice President & CFO
Sold499,730$9.33$4.7M
2025-03-17Patel Tushar Bhikhubhai
10% owner
Sold5,000,000$8.35$41.8M
2025-03-07BOYER ANDREW S
Executive Vice President
Sold125,000$8.89$1.1M

See AMRX on the chart

Every insider buy and sell for AMRX plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.